Skip to main content
. 2020 Jan 14;10(1):135. doi: 10.3390/biom10010135

Table 1.

Metabolic enzymes involved in oxidative stress and energy metabolism whose increased expression correlates with neoplastic transformation, prognosis and/or chemoresistance in different tumors. BC: Breast Cancer; CRC: Colorectal Carcinoma; DLBC: Diffuse Large B cell Lymphoma; EC: Endometrial cancer; HCC: Hepatocellular Carcinoma; LC: Lung Cancer; MESO: Mesothelioma; OC: Ovarian Cancer; OS: Osteosarcoma; PC: Prostate cancer.

Protein Function Tumor Type References
Thioredoxin-1 (Trx1) Redox protein member of thioredoxin system which plays a crucial role in the cellular redox homeostasis DLBCL [24]
CRC [107]
Thioredoxin reductase-2 (TrxR2) Member of the family of pyridine nucleotide-disulfide oxidoreductases, component of the antioxidant thioredoxin system HCC [108]
OS [109]
LC [110]
Peroxiredoxin 3 (Prx3) Antioxidant enzyme
with mitochondrial localization, member of the thioredoxin system
BC [111]
HCC [112]
MESO [113]
EC [114]
PC [115]
SIRT1 NAD+-dependent protein deacetylase, plays key roles in DNA damage response and metabolic adaptation to energy stress. Along with PGC1α, is involved in chemotherapy-induced shift to OXPHOS in CRC cells CRC [47,116]
SIRT5 NAD-dependent protein lysine demalonylase,
desuccinylase and deglutarylase able to remove malonyl, succinyl, and glutaryl groups from the lysine residues of proteins
CRC [54]
Hexokinase II (HK2) Catalyzes the phosphorylation of glucose to generate glucose-6-phosphate in the first step of glycolysis.
It promotes chemoresistance by enhancing cisplatin-induced autophagy
OC [117,118]
Transketolase (TKT) Ezyme catalyzing important reaction both in the Calvin cycle and in pentose phosphate pathway BC [57]